104 related articles for article (PubMed ID: 3686468)
1. [Activities of a regional drug monitoring center. What to evaluate, how and for what purpose].
Péré JC; Haramburu F; Bégaud B; Barat C; Laborde B; Albin H
Therapie; 1987; 42(4):351-8. PubMed ID: 3686468
[No Abstract] [Full Text] [Related]
2. [Drug monitoring].
Royer RJ
Bull Soc Ophtalmol Fr; 1985 Nov; Spec No():11-30. PubMed ID: 4064240
[No Abstract] [Full Text] [Related]
3. [Assessment of the severity and cost of adverse drug effects recorded at the Paris-Fernand Widal Drug Monitoring Center during 2 monthly periods].
Castot A; Lagier G; Merigot P; de Crémoux P; Efthymiou ML
Therapie; 1987; 42(4):365-7. PubMed ID: 3686469
[No Abstract] [Full Text] [Related]
4. [Microcomputerized data bank of nephrotoxic drugs at the Paris-Saint Antoine Regional Drug Monitoring Center].
Hamel JD; Biour M; Cheymol G
Therapie; 1986; 41(5):327-9. PubMed ID: 3810519
[No Abstract] [Full Text] [Related]
5. Drug information services at Eli Lilly and Company.
Pfeil-Doyle JL; Jones MD; Oberlin JA; Benitez J
Am J Hosp Pharm; 1990 Sep; 47(9):1996-8. PubMed ID: 2220850
[No Abstract] [Full Text] [Related]
6. [Comprehensive detection of severe, potentially life-threatening drug side effects].
Schönhöfer PS; Wessely-Stickel B; Schulte-Sasse H; Werner W
Verh Dtsch Ges Inn Med; 1989; 95():687-90. PubMed ID: 2603504
[No Abstract] [Full Text] [Related]
7. [Detection of drug side effects at the Heidelberg Medical Clinic].
Jacubeit T; Drisch D
Verh Dtsch Ges Inn Med; 1989; 95():690-3. PubMed ID: 2603505
[No Abstract] [Full Text] [Related]
8. [Adverse effects and insufficient information in Fass].
Ekholm ML
Lakartidningen; 2007 Jul 25-Aug 7; 104(30-31):2179. PubMed ID: 17824377
[No Abstract] [Full Text] [Related]
9. Drug information: how much is too much? Suggestions for improving the sources of drug information.
Devetski RL
Indiana Med; 1986 Apr; 79(4):368-9. PubMed ID: 3711651
[No Abstract] [Full Text] [Related]
10. Michigan regional drug information network. 3. Utilization of information received from a drug information center.
Pearson RE; Schmalgemeier W; Bendall M; Mehta P
Am J Hosp Pharm; 1972 Mar; 29(3):229-34. PubMed ID: 5028475
[No Abstract] [Full Text] [Related]
11. [Brief review of documents with data on the toxicity and hazards of chemical substances developed in various countries].
Sanotskiĭ IV; Smirnova ON
Gig Tr Prof Zabol; 1989; (3):33-6. PubMed ID: 2744552
[TBL] [Abstract][Full Text] [Related]
12. [Organization and results of drug vigilance in France].
Bégaud B; Chaslerie A; Haramburu F
Rev Epidemiol Sante Publique; 1994; 42(5):416-23. PubMed ID: 7973001
[TBL] [Abstract][Full Text] [Related]
13. [Early identification of the tolerance profile of agents under clinical investigation].
Palminteri R; Sarazin E; Narbonne G
Therapie; 1987; 42(4):343-6. PubMed ID: 3317981
[No Abstract] [Full Text] [Related]
14. [A searchable data bank on the Minitel system for iatrogenic pathology and drug interactions designed for practitioners].
Escousse A; Bianchetti D; Sgro C; Parfait S; Perceau JP
Therapie; 1987; 42(1):57. PubMed ID: 3590066
[No Abstract] [Full Text] [Related]
15. Drug interaction microcomputer software evaluation: Drug Therapy Screening System (DTSS).
Poirier TI; Giudici RA
Hosp Pharm; 1990 Aug; 25(8):738-41, 744. PubMed ID: 10170582
[TBL] [Abstract][Full Text] [Related]
16. [Information systems for phase III and IV clinical trials].
Alamercery Y; Begaud ; Chastang ; Derzko ; Dupuis Y; Gomeni R; Go L; Lemarie ; Mery ; Wartelle
J Pharmacol; 1986; 17 Suppl 1():12-8. PubMed ID: 3747536
[No Abstract] [Full Text] [Related]
17. Management of medicines information for patient safety.
Pappa D; Telonis P; Stergioulas LK
J Telemed Telecare; 2006; 12 Suppl 1():34-6. PubMed ID: 16884574
[TBL] [Abstract][Full Text] [Related]
18. [Drug control within the EEC II: good possibilities for Sweden].
Strandberg K
Lakartidningen; 1992 Jan; 89(4):178-9. PubMed ID: 1734147
[No Abstract] [Full Text] [Related]
19. Short communication: pattern of adverse drug reaction related queries received by the drug information centre of a tertiary care teaching hospital.
Jimmy B; Jose J; Rao PG
Pak J Pharm Sci; 2007 Oct; 20(4):333-9. PubMed ID: 17604259
[TBL] [Abstract][Full Text] [Related]
20. [Forms of information supplied by regional drug monitoring centers. Assessment of the activity during 1984].
Lavarenne J; Evreux JC
Therapie; 1986; 41(5):323-6. PubMed ID: 3810517
[No Abstract] [Full Text] [Related]
[Next] [New Search]
